Company Overview and News

2
IEX hires former ISE executive Ilyevsky to lead market development

2018-07-09 reuters
NEW YORK (Reuters) - U.S. stock exchange operator IEX Group said on Monday it has hired Boris Ilyevsky, a former long-time executive of the options-focused International Securities Exchange (ISE), to lead market development, including a potential expansion into options.
IEX NDAQ DBOEY DTK ICE DBOEF

3
Britain might not play fair with Brexit - Deutsche Boerse chief

2018-06-21 reuters
FRANKFURT, June 21 (Reuters) - Britain may bend the rules to defend London’s standing as a global investment hub after leaving the European Union, the head of the company that runs the Frankfurt Stock Exchange warned on Thursday, raising the stakes in a duel for post-Brexit financial supremacy.
DBOEY LNSTY DBOEF

12
This German Fintech May Soon Be More Valuable Than Deutsche Bank - Bloomberg

2018-06-15 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
WCAGY V DB DBOEY DBOEF WRCDF

44
Resurgent trading helped global exchanges' revenues hit record in 2017 - report

2018-06-12 reuters
LONDON (Reuters) - A surge in trading and booming demand for information services drove global exchange revenues to a record high in 2017, a report by consultancy Burton Taylor said on Tuesday.
DBOEY 7018 CME ICE DBOEF

3
PRESS DIGEST- British Business - June 12

2018-06-12 reuters
June 12 (Reuters) - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy.
DBOEY WTG RYAOF LNSTY DBOEF RYAAY QUPPF

3
Share trading platform Aquis to raise £12m with listing on Aim

2018-06-11 telegraph.co.uk
Challenger stock exchange Aquis will float on the junior Aim market to bolster its war chest to take on larger rivals, such as the London Stock Exchange and Deutsche Boerse.
DBOEY LNSTY DBOEF

2
Continental AG: More Than Just Tires, But I Still Prefer Michelin

2018-06-07 seekingalpha
Continental often gets mistaken for being 'just' a tire manufacturer, but only 25% of its revenue is generated in the tire division.
DBOEY CTTAY CTTAF DBOEF

2
UPDATE 1-EU lawmaker rules out "mutual recognition" for UK financial firms

2018-06-06 reuters
LONDON (Reuters) - The City of London financial district’s preferred option for future trading relations with the European Union after Brexit won’t work, a senior EU lawmaker said on Wednesday.
DBOEY DBOEF

61
Deals of the day-Mergers and acquisitions

2018-05-30 reuters
May 30 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by Wednesday 1430 GMT on Wednesday: ** Twenty-First Century Fox Inc will hold a special meeting on July 10th for its stockholders to vote on a proposed merger with Walt Disney Co, the company said. ** Shares of NXP Semiconductors NV fell 5 percent after China’s latest warning against U.S. trade threats dulled hopes of an early approval by Beijing for Qualcomm’s $44 billion acquisition of the chipmaker.
FOX GCAP DB DBOEY LBTY LBTYB BC94 SMSN WCG LBTYA BWLLF LPG ZNGA BWLLY LBTYK LILAB LILAK DBOEF FOXA DIS SMSD LILA

2
Deutsche Boerse to include tech stocks in MDAX and SDAX in index shakeup

2018-05-19 reuters
FRANKFURT (Reuters) - Deutsche Boerse, the German stock exchange operator, is planning a major shakeup of the composition of three key indexes later this year that affects technology stocks.
DBOEY DBOEF

9
Singapore's China-Backed Exchange Set to Start Trading on May 25 - Bloomberg

2018-05-17 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
SPXCY DBOEY SPXCF ICE DBOEF S68

1
Deutsche Borse (DBOEY) Investor Presentation - Slideshow

2018-05-17 seekingalpha
The following slide deck was published by Deutsche Boerse AG ADR in conjunction with this event.
DBORY DBOEY

2
German bourse to cut 50 managerial jobs

2018-05-16 thestar.com.my
The German exchange group’s chief executive officer told shareholders yesterday that he wants to cut as many as 50 management jobs as part of a plan to lower its annual running costs by €100mil (US$118mil) by the end of 2020.
DBOEY DBOEF

2
Deutsche Boerse to Cut as Many as 50 Management Positions - Bloomberg

2018-05-16 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
DBOEY DBOEF

3
Deutsche Boerse CEO is on the lookout for acquisitions

2018-05-16 channelnewsasia
The new chief executive officer of Deutsche Boerse is on the lookout for acquisitions as one of the pillars of the German stock exchange operator's growth strategy.
DBOEY LNSTY DBOEF

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

8h - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

9h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 251542106